GeriPal

JUNE 12, 2025

So in my practice, I typically recommend multi fraction or higher dose regimens for patients who have extra osseous extension or complicated bone Metastases, which, you know, most of the data surrounding equivalency of pain relief is in this sort of uncomplicated bone metastasis population. There may be co pays or things like that.

Patient-Centered 102

Patient-Centered Referral Patients IT 102

GeriPal

MARCH 9, 2023

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Alex: It’s complicated. We, for very complicated reasons, ended up with niacin. Legalization is moving forward in several states , following the lead of Oregon and Colorado. Eric: Yeah.

Patient-Centered 91

Patient-Centered Community IT Medical 91

GeriPal

JUNE 6, 2024

Don 13:50 Well, you know, I think one of the issues, though, when you ask about prevalence data, especially, say, in the oncology world, not only does it matter about how you ask the questions, but because it’s such a complicated topic, people may infer very different things as to what you’re talking about. Sharon 15:21 Right.

Illness 130

Illness IT Physicals Patients 130